logo-loader
RNS
viewFeedback PLC

Bleepa - the clinical messaging app - at NHS Expo

/**/ sup{font-size:80%}h1{margin-top:24.0pt;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;line-height:107%;font-size:24.0pt;font-family:"Calibri","sans-serif";}h2{margin-top:18.0pt;margin-right:0cm;margin-bottom:4.0pt;margin-left:0cm;line-height:107%;font-size:18.0pt;font-family:"Calibri","sans-serif";}h3{margin-top:14.0pt;margin-right:0cm;margin-bottom:4.0pt;margin-left:0cm;line-height:107%;font-size:14.0pt;font-family:"Calibri","sans-serif";}h4{margin-top:12.0pt;margin-right:0cm;margin-bottom:2.0pt;margin-left:0cm;line-height:107%;font-size:12.0pt;font-family:"Calibri","sans-serif";}h5{margin-top:11.0pt;margin-right:0cm;margin-bottom:2.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";}h6{margin-top:10.0pt;margin-right:0cm;margin-bottom:2.0pt;margin-left:0cm;line-height:107%;font-size:10.0pt;font-family:"Calibri","sans-serif";}link{ color: blue }visited{ color: purple } .p{size:595.3pt 841.9pt;margin:2.0cm 2.0cm 2.0cm 2.0cm;}div.p{}p.az{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal;border:none}span.ax{font-size:20.0pt; font-family:"Arial","sans-serif";color:black}p.ba{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:4.75pt;margin-bottom: 0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal; border:none}span.av{font-size:16.0pt;font-family:"Arial","sans-serif"; color:black}span.au{font-size:12.0pt;font-family:"Arial","sans-serif"}span.at{font-size:16.0pt;font-family:"Arial","sans-serif";color:black}p.bb{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";border: none; font-div: italic; line-height: normal; margin-bottom: 0cm; margin-left: 0cm; margin-right: 4.75pt; margin-top: 0cm; text-align: justify}span.ar{font-size:12.0pt;font-family:"Arial","sans-serif"; color:black} p.bc{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal}span.ap{font-size:10.0pt;font-family:"Arial","sans-serif"}p.bd{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify}p.be{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-div: italic; line-height: normal; margin-bottom: 0cm; text-align: justify}p.bf{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal}span.ak{font-size:8.0pt;font-family: "Arial","sans-serif"}span.aj{font-size:8.0pt; font-family:"Arial","sans-serif"}p.bg{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";line-height: normal; margin-bottom: 0cm; text-align: center}span.ai{font-size:10.0pt;font-family: "Arial","sans-serif"}p.bh{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";border: none; font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify} span.ag{font-size:10.0pt; font-family:"Arial","sans-serif"}table.bi{margin-left:-5.4pt;border-collapse:collapse}td.ae{width:258.55pt;padding:0cm 5.4pt 0cm 5.4pt}td.aa{width:180.55pt;padding:0cm 5.4pt 0cm 5.4pt}span.ad{color:black}p.bj{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal;border:none}span.ac{font-size:10.0pt; font-family:"Arial","sans-serif";color:#0070C0}tr.x{height:22.0pt}td.z{width:258.55pt;padding:0cm 5.4pt 0cm 5.4pt; height:22.0pt}td.y{width:180.55pt;padding:0cm 5.4pt 0cm 5.4pt; height:22.0pt} span.w{font-size:10.0pt;font-family:"Arial","sans-serif"; color:black}span.v{font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0}span.t{font-size: 10.0pt;font-family:"Arial","sans-serif"}p.bk{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:.05pt;margin-right:5.55pt;margin-bottom: 0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal; border:none}span.r{font-size:10.0pt; font-family:"Arial","sans-serif";color:black}span.q{font-size:10.0pt;font-family:"Arial","sans-serif"; color:#0563C1} /**/
RNS Number : 1146L
Feedback PLC
04 September 2019
 

Feedback plc

 

Bleepa - the revolutionary clinical messaging app - showcased at NHS Expo 2019

 

Feedback Medical unveils ground-breaking medical imaging product

 

Cambridge, 4 September 2019: As previously announced, Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, is unveiling its new revolutionary clinical messaging product, Bleepa, to over 6,000 conference delegates at NHS Expo in Manchester on 4-5 September 2019.

 

Dr Tom Oakley, CEO of Feedback, commented:

 

"We are demonstrating Bleepa for the first time at Expo with leaders who are driving digital innovation across the NHS. The role of digital technology in revolutionising patient care is central to the NHS Long Term Plan and we believe Bleepa sits firmly at the heart of this movement, enabling clinicians to share high quality medical images and discuss how to give the best possible patient care securely and quickly via mobile devices."

 

Bleepa is an innovative new app based on Feedback's Cadran technology, which allows medical staff to securely view and discuss high quality medical grade images on mobile devices. The app will display images directly from the hospital's Picture Archive Communication System (PACS).  Bleepa can display any type of image including X-rays, CTs, MRIs and ultrasound studies allowing users to easily scroll through image slices and annotate areas of interest. Questions can be asked alongside annotations and submitted into the chat where they can be securely reviewed by colleagues at the swipe of a finger, with instant access to the original image.

 

Bleepa enables faster clinical decisions as doctors will be able to share, review and discuss images including screen sharing with multiple staff, both accelerating and improving patient care. All data and resulting decisions will be stored in hospital records for later review.

 

Currently, it is only possible to view medical grade images on desktop computers and discuss them by telephone.  According to BMJ Innovations, 97% of hospital doctors routinely use WhatsApp to communicate about patients.1 This increasing trend for clinicians to use personal devices to discuss patient care and make clinical decisions is more convenient and efficient than traditional methods of clinical communication.  However, these images are not of sufficient quality to make clinical decisions and sharing data in this way breaches data protection legislation, leaving hospitals and individual staff open to the risk of litigation.

 

The Directors believe Bleepa will be the leading communication tool on the market and will be a CE marked medical device.

 

Bleepa will be demonstrated and available for pre-order on stand 29 at NHS England Health and Care Innovation Expo at Manchester Central, 4 - 5 September 2019. For more information see www.bleepa.com.

 

1 O'Sullivan DM, O'Sullivan E, O'Connor M, et al WhatsApp Doc? BMJ Innovations 2017;3:238-239.

 

-Ends-

 

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

[email protected]

 

 

Instinctif Partners

Rozi Morris / Phillip Marriage

+44 (0)20 7457 2020

[email protected]

 

 

Notes to editors

 

About Feedback plc - www.fbk.com

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited.  Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

 

Feedback has launched Bleepa, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS).  For more information on Bleepa™, see www.bleepa.com.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NRAUOSBRKKAKRAR

Quick facts: Feedback PLC

Price: 1.2

Market: LSE
Market Cap: £6.48 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Restructure sees Feedback Plc positioned for growth

Alastair Riddell, chairman of Feedback plc (LON:FDBK), tells Proactive's Andrew Scott they've merged two of their subsidiaries as part of plans to restructure and simplify the business. Feedback snapped up Cambridge Computed Imaging and TexRAD back in 2014 and both have been operating as...

on 19/4/18